BH
Insider
Beth Hecht
See RemarksBeth Hecht (See Remarks) filed 10 Form 4 reports in the trailing twelve months (0 purchases, 10 sales), most often in Xeris Biopharma Holdings, Inc. (XERS). The largest single filing was $141K of XERS (16,666 sh × $8.49, as filed), executed Sep 1.
Add to watchlistReturn, ttmiAverage return per filing, trailing twelve months
–
no purchases on file
Delay-adjustediThe same average, entered at disclosure dates
–
returns measure stock purchases only
Filings, ttm
10
0 buys · 10 sells
Median delay
–
execution → disclosure
Volume, ttmiDollar value disclosed in the trailing twelve months
$1.2M
shares × price, as filed
Last traded
Sep 1
Filed Sep 1
Median ADV $16.5M across their filed names
Open performance→Volume by month
Buys $0
Sells $1.4M
Shares × price, as filed · by filing month · past 24 months
Sectors filed on
Healthcare
10 filings
Sector per market data · by filing · past 12 months
Most traded names
XERS
Xeris Biopharma Holdings, Inc.
XERS · 0 buys · 11 sells
11 filings
Recent filings
XERSSALE
Xeris Biopharma Holdings, Inc.
View filing →
$117K16,667 sh × $7.01
Exec Dec 1 2025
Filed Dec 2 2025 · 5:30 PM ET XERSSALE Xeris Biopharma Holdings, Inc. View filing → $123K
16,667 sh × $7.40
Exec Nov 11 2025
Filed Nov 13 2025 · 5:30 PM ET XERSSALE Xeris Biopharma Holdings, Inc. View filing → $217K
40,000 sh × $5.43
Exec Mar 20 2025
Filed Mar 21 2025 · 5:30 PM ET